| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Intech Biopharm Corporation (TWO: 6461)
6461 Technical Analysis
5
| As on 30th Jun 2025 6461 STOCK Price closed @ 17.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 28.61 & Strong Sell for SHORT-TERM with Stoploss of 29.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
6461STOCK Price
| Open | 17.75 | Change | Price | % |
| High | 17.95 | 1 Day | -0.10 | -0.56 |
| Low | 17.50 | 1 Week | -0.75 | -4.08 |
| Close | 17.65 | 1 Month | -0.75 | -4.08 |
| Volume | 160715 | 1 Year | -13.60 | -43.52 |
| 52 Week High 32.10 | 52 Week Low 16.60 | ||||
TWO Taiwan Most Active Stocks
| 3297 | 53.40 | -3.44% |
| 6274 | 227.50 | 2.48% |
| 1815 | 36.20 | 2.55% |
| 4931 | 96.10 | -8.04% |
| 3294 | 39.45 | 2.73% |
| 3128 | 45.10 | 10.00% |
| 5251 | 59.70 | -0.50% |
| 6140 | 42.60 | -3.62% |
| 5439 | 238.50 | -0.62% |
| 3374 | 147.50 | -5.45% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 6461 Daily Charts |
6461 Intraday Charts |
Whats New @ Bazaartrend |
6461 Free Analysis |
|
|
6461 Important Levels Intraday
| RESISTANCE | 18.52 |
| RESISTANCE | 18.24 |
| RESISTANCE | 18.07 |
| RESISTANCE | 17.90 |
| SUPPORT | 17.40 |
| SUPPORT | 17.23 |
| SUPPORT | 17.06 |
| SUPPORT | 16.78 |
6461 Forecast July 2025
| 4th UP Forecast | 25.84 |
| 3rd UP Forecast | 23.21 |
| 2nd UP Forecast | 21.59 |
| 1st UP Forecast | 19.97 |
| 1st DOWN Forecast | 15.33 |
| 2nd DOWN Forecast | 13.71 |
| 3rd DOWN Forecast | 12.09 |
| 4th DOWN Forecast | 9.46 |
6461 Weekly Forecast
| 4th UP Forecast | 22.18 |
| 3rd UP Forecast | 20.73 |
| 2nd UP Forecast | 19.83 |
| 1st UP Forecast | 18.93 |
| 1st DOWN Forecast | 16.37 |
| 2nd DOWN Forecast | 15.47 |
| 3rd DOWN Forecast | 14.57 |
| 4th DOWN Forecast | 13.12 |
6461 Forecast2025
| 4th UP Forecast | 52.53 |
| 3rd UP Forecast | 41.34 |
| 2nd UP Forecast | 34.43 |
| 1st UP Forecast | 27.51 |
| 1st DOWN Forecast | 7.79 |
| 2nd DOWN Forecast | 0.87 |
| 3rd DOWN Forecast | -6.04 |
| 4th DOWN Forecast | -17.23 |
Intech Biopharm Corporation ( TWO Taiwan Symbol : 6461 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
6461 Business Profile
Intech Biopharm Corporation focuses on developing and manufacturing generic drugs to treat respiratory diseases. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform to treat asthma and chronic pulmonary obstructive disease; and dry powder inhaler. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation is headquartered in Taipei, Taiwan. Address: No. 36, Ruiguang Road, Taipei, Taiwan, 114
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service